A spectral approach for heart rate fluctuations analysis

Human head exposure to a 37 Hz electromagnetic field: Effects on blood pressure, somatosensory perception, and related parameters

Previous studies have shown that exposure to an electromagnetic field (EMF) of 37 Hz at a flux density of 80 microT peak enhances nociceptive sensitivity in mice. Here we examined the effects on pain sensitivity and some indexes of cardiovascular regulation mechanisms in humans by measuring electrical cutaneous thresholds, arterial blood pressure, heart rate and its variability, and stress hormones. Pain and tolerance thresholds remained unchanged after sham exposure but significantly decreased after electromagnetic exposure. Systolic blood pressure was significantly higher during electromagnetic exposure and heart rate significantly decreased, both during sham and electromagnetic exposure, while the high frequency (150-400 mHz) component of heart rate variability, which is an index of parasympathetic activity, increased as expected during sham exposure but remained unchanged during electromagnetic exposure. Cortisol significantly decreased during sham exposure only. These results show that exposure to an EMF of 37 Hz also alters pain sensitivity in humans and suggest that these effects may be associated with abnormalities in cardiovascular regulation.

Autonomic control of heart rate variability in vasovagal syncope: a study of the nighttime period in 24-hour recordings

Patients experiencing vasovagal syncope have been claimed to show reduced vagal tone over 24-hour electrocardiography recordings. Assessment of sympathovagal balance in the absence of external stimuli, i.e., nighttime electrocardiography monitoring, might help to clarify if increased sympathetic activity is present in these patients. Heart rate variability was examined at nighttime in 40 patients with recurrent episodes of vasovagal syncope within the last 2 years (22 men; mean age, 37 years) and 20 comparable healthy volunteers. Time domain parameters (pNN50 [proportion of successive RR intervals difference >50 ms in %] and rMSSD [root-mean-square successive difference of RR intervals in ms]), indexes of vagal tone, and frequency domain parameters, expressing the overall heart rate variability, vagal (high frequency [HF]) and sympathetic (low frequency [LF]) activity, and autonomic balance (LF/HF ratio) were compared between groups by Mann-Whitney test. Significant (p<0.05) reduction of heart rate variability and vagal tone (pNN50 and rMSSD) were found for patients with vasovagal syncope, together with increased sympathetic activity (increased LF/HF ratio). These findings could open new insights in the pathogenesis of vasovagal syncope because of the shift of the autonomic balance toward sympathetic activation near the syncopal episode.

Power spectrum analysis of heart rate variations in the early detection of diabetic autonomic neuropathy

Power spectrum analysis of the R-R interval was used in 20 controls and in two groups of type I (insulin dependent) diabetics (27 patients) to detect changes in total power or in its components (low frequency and high frequency) that might be considered an early evidence of impairment of cardiac autonomic nervous system control. A significant difference between controls and severe diabetics (with autonomic involvement) was found in all components. In the early stage of diabetes without evidence of autonomic involvement, an absolute reduction of the low frequency component in the standing position and a significant reduction of the percentage increase compared with the lying position, was found to discriminate diabetics from controls. The occurrence of somatic neuropathy was unrelated to changes in autonomic function. These data indicate that: (1) power spectrum analysis is sensitive enough to detect cardiac autonomic neuropathy in diabetics, where standard methods fail; (2) power spectrum analysis is the method of choice in the early stages; (3) in severe type I dependent diabetes there is a reduction of power spectrum analysis total power and a defective response to standing up; (4) cardiac autonomic neuropathy develops independently from somatic neuropathy.